BLLN Billiontoone Earnings and EPS analysis

Relative Growth: Rel. Growth: 66

Relative Strength: Rel. Strength: 75

Relative Valuation: Rel. Valuation: 17

Relative Profitability: Rel. Profitability: 87

EPS in 2026 (TTM): $0.84

Last Report Period Date: Jun 30, 2026

As of September 2026, BLLN's current EPS stands at $0.84, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of $0.18, which marks an increase compared to its EPS of -$4.12 in 2024. BLLN reported an EPS of $0.17 for the quarterly report ending on Jun 30, 2026.

BLLN earnings history

Historical annual and quarterly earnings per share (EPS) data for Billiontoone

EPS (TTM)

$0.84

EPS Growth YoY (Quarterly)

950%

EPS (Quarterly)

$0.17

EPS Growth (Quarterly)

-56.4%

For 2025, Billiontoone's EPS was $0.18, an increase of 104.4% from -$4.12 in 2024. For the fiscal quarter that ended on Jun 30, 2026, the per-share earnings was $0.17, showing a 950% increase from the same quarter last year. For the twelve months ending June 2026, the EPS is $0.84. For the year 2024, the yearly earnings per share was -$4.12, marking an increase of 51.2% from 2023.

BLLN EPS vs price chart

BLLN EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

950%

EPS growth YoY

104.4%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

During the last 12 months, Billiontoone has seen an EPS growth of 950% (YoY, quarterly).

BLLN Earnings Waterfall

Breakdown of revenue, profit and net income for Billiontoone

BLLN Earnings vs Peers

What are the earnings of BLLN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
CDNA Caredx Inc	25.26	-140%	N/A	N/A
ILMN Illumina Inc	47.29	171.1%	N/A	4.1%
BLLN Billiontoone Inc - Class A	136.21	104.4%	N/A	N/A
FLGT Fulgent Genetics Inc	N/A	-39.7%	N/A	N/A
GH Guardant Health Inc	N/A	6.7%	N/A	N/A
QDEL QuidelOrtho Corporation	N/A	45.4%	N/A	N/A
MYGN Myriad Genetics Inc	N/A	-180.1%	N/A	N/A
NTRA Natera Inc	N/A	0.7%	N/A	N/A
TWST Twist Bioscience Corp	N/A	63.9%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.